In a pancreatic cancer cell study by Bian et al. [57], expression of TAOK3 was required to support the cancer stem cell-enriching spheroid growth, and knockdown of TAOK3 decreased expression of stem cell traits, spheroid formation, and sensitized cells to gemcitabine treatment. This evidence concerns the gene TAOK3 and familial pancreatic carcinoma.